Used in pharmaceutical research as a key intermediate in the synthesis of PPAR (peroxisome proliferator-activated receptor) agonists, particularly targeting PPARδ. It plays a role in developing treatments for metabolic disorders such as type 2 diabetes, dyslipidemia, and obesity due to its ability to modulate lipid metabolism and insulin sensitivity. Its carboxylic acid functional group allows for easy derivatization into esters or amides to improve pharmacokinetic properties. Also explored in prodrug strategies to enhance oral bioavailability. Shows potential in anti-inflammatory and neuroprotective applications through modulation of metabolic pathways.